Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Glaucoma, Neovascular

• A Study on the Treatment Strategy of NVG Secondary to PDR
• Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
• KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
• Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injecti
• Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma
• Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
• Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study
• Ahmed Glaucoma Valve Surgery With Mitomycin-C
• Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
• Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
• Analysis of Aqueous and Vitreous Humor
• Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
• An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
• Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
• Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
• Lucentis for New Onset Neovascular Glaucoma
• Oculusgen (Ologen) Glaucoma MMC Control in Estonia
• Effects of Travoprost on Neovascular Glaucoma
• Intravitreal Bevacizumab for Neovascular Glaucoma